all you really have to compare it to is AGN at a 70 million market cap before GLP and phase 1 studies in 2021, NYR is a more effective treatment with no need of combining it with thrombotics and a single therapy and not a dual therapy which is already proven to work
Current market cap is 22 million with 5 million in cash and 3-4 million in rebates coming after July 1st. Got a significant rerate to go as it was at 40 cents last time without it being proven and this current results exceeded modelling so previous highs will be tested short term
- Forums
- ASX - By Stock
- Nyrada Talks PreClinical Success with 180 Markets
all you really have to compare it to is AGN at a 70 million...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $18.22M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $23.10K | 229.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 62000 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 38990 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 62000 | 0.100 |
1 | 10000 | 0.099 |
2 | 16122 | 0.098 |
4 | 163312 | 0.096 |
1 | 105270 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 38990 | 4 |
0.110 | 40666 | 3 |
0.115 | 420716 | 4 |
0.120 | 677163 | 8 |
0.125 | 30000 | 1 |
Last trade - 14.22pm 08/10/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |